BUSINESSThe Dales Report
TDR Reviews a Canadian Medical Cannabis Model for U.S. Operators
The Dales Report interviewed Avicanna CEO Aras Azadian about standardized noncombustible products, pharmacist-led patient support, insurance coverage and clinic integration in Canada. For Oklahoma operators, the discussion highlights product-development and care-model opportunities that may become more important as federal rescheduling separates medical cannabis from conventional retail.
Published Sep 17, 2026
Read the full article at The Dales Report#national#rescheduling#research#compliance
Read the original source
Leafy summaries provide industry context. Confirm details with The Dales Report.